Skip to main content

Month: September 2022

Fancamp Exploration Ltd. Acquires Securities of KWG Resources Inc.

VANCOUVER, British Columbia, Sept. 02, 2022 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp”) is pleased to announce that, on September 1, 2022, KWG Resources Inc. (“KWG”), an exploration stage mining company headquartered in Ontario, issued the following securities to Fancamp: (a) a secured convertible promissory note of KWG (the “Secured Convertible Promissory Note”) in the aggregate principal amount of C$34,500,000 (the “Principal Amount”), convertible into multiple voting shares in the capital of KWG (“MVS”); and (b) warrants (the “Warrants”) to purchase MVS. The Secured Convertible Promissory Note and the Warrants were issued by KWG to Fancamp as partial consideration for the acquisition by KWG of all of the right, title and interests beneficially owned by Fancamp in and to the “Koper Lake-McFaulds” mineral properties,...

Continue reading

BLINK CHARGING TO PRESENT AT BARCLAYS CEO ENERGY-POWER CONFERENCE

Miami Beach, FL, Sept. 02, 2022 (GLOBE NEWSWIRE) — Blink Charging Co. (Nasdaq: BLNK, BLNKW) (“Blink” or the “Company”), a leading owner, operator, and provider of electric vehicle (EV) charging equipment and services, today announced that Michael D. Farkas, Chairman and Chief Executive Officer, will be presenting at the Barclays CEO Energy-Power Conference in New York City on Wednesday, September 7, 2022 at 12:40 pm ET. Mr. Farkas will also be available throughout the day for one-on-one meetings. Interested investors can register to view the presentation at this link. About Blink Charging  Blink Charging Co. (Nasdaq: BLNK, BLNKW), a leader in electric vehicle (EV) charging equipment, has deployed over 51,000 charging ports across 25 countries, many of which are networked EV charging stations, enabling EV drivers to easily charge...

Continue reading

Lesaka to Participate at Upcoming Conferences in New York City in Mid-September 2022

JOHANNESBURG, South Africa, Sept. 02, 2022 (GLOBE NEWSWIRE) — Lesaka Technologies, Inc. (“Lesaka” or the “Company”) (NasdaqGS:LSAK; JSE: LSK) today announced that Chris Meyer, Group CEO and Naeem Kola, Group CFO will participate in-person at the H.C. Wainright 24th Annual Global Investment Conference on Wednesday, September 14, 2022 and the UBS Fintech Conference on Thursday, September 15, 2022 in New York City. The Company will be hosting one-on-one meetings at both conferences. About Lesaka (www.lesakatech.com) Lesaka Technologies, (Lesaka™) is a South African Fintech company that utilizes its proprietary banking and payment technologies to deliver superior financial services solutions to merchants (B2B) and consumers (B2C) in Southern Africa. Lesaka’s mission is to drive true financial inclusion for both merchant and consumer...

Continue reading

Big River shareholders vote in favour of acquisition by Aura

ROAD TOWN, British Virgin Islands, Sept. 02, 2022 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX:ORA, B3:AURA33) (“Aura” or the “Company”) is pleased to inform that Big River Gold Limited (ASX:BRV) (“Big River”) announced today in a Press Release that the requisite majorities of each class of shareholders voted in favour of the proposed scheme of arrangement (“Scheme”), pursuant to which Borborema LLC, an indirect wholly-owned subsidiary of Aura (“BidCo”) will acquire all of the shares in Big River (other than the shares held by Dundee Resources). As previously disclosed, Aura will hold its interest in BidCo through an intermediate holding company (“JVCo”) with Dundee Resources which agreed, subject to certain limited conditions, to receive shares in JVCo, in lieu of the cash consideration, in order to indirectly maintain an equity...

Continue reading

Benitec Biopharma Releases Full Year 2022 Financial Results and Provides Operational Update

HAYWARD, Calif., Sept. 02, 2022 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “the Company”), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference (“ddRNAi”) platform, today announced financial results for its Fiscal Year ended June 30, 2022. The Company has filed its annual report on Form 10-K for the quarter ended June 30, 2022, with the U.S. Securities and Exchange Commission. “We continue to move closer to the initiation of the clinical evaluation of BB-301,” said Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec Biopharma. “The Benitec team remains committed to improving the lives of patients suffering from Oculopharyngeal Muscular Dystrophy.” Operational...

Continue reading

Hurco Reports Third Quarter Results for Fiscal 2022

INDIANAPOLIS, Sept. 02, 2022 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the third fiscal quarter ended July 31, 2022. Hurco recorded net income of $1,238,000, or $0.18 per diluted share, for the third quarter of fiscal 2022, compared to net income of $1,568,000, or $0.23 per diluted share, for the corresponding period in fiscal 2021. For the nine months of fiscal 2022, Hurco reported net income of $6,802,000, or $1.01 per diluted share, compared to net income of $4,668,000, or $0.70 per diluted share, for the corresponding period in fiscal 2021. Sales and service fees for the third quarter of fiscal 2022 were $57,640,000, an increase of $3,462,000, or 6%, compared to the corresponding prior year period, and included an unfavorable currency impact of $4,273,000, or 8%, when translating foreign...

Continue reading

SLR Investment Corp. Announces Monthly Distribution for September 2022

NEW YORK, Sept. 02, 2022 (GLOBE NEWSWIRE) — SLR Investment Corp. (the “Company”) (NASDAQ: SLRC), today declared a distribution of $0.136667 per share for the month of September 2022. The distribution is payable on October 4, 2022 to stockholders of record as of September 20, 2022. The specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year. ABOUT SLR INVESTMENT CORP. SLR Investment Corp. is a closed-end investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. A specialty finance company with expertise in several niche markets, the Company generally invests directly and indirectly in leveraged, U. S. middle market companies primarily in the form of cash flow senior secured loans, including...

Continue reading

Navient President and CEO to present at Barclays 2022 Global Financial Services Conference on Sept. 13

WILMINGTON, Del., Sept. 02, 2022 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI), a leader in technology-enabled education finance and business processing solutions, today announced that President and CEO Jack Remondi will participate in a fireside chat at the Barclays 2022 Global Financial Services Conference on Tuesday, Sept. 13. Remondi will deliver remarks at 12:00 p.m. ET. The webcast, along with any written materials or slides used during the presentation, will be available at Navient.com/investors. A replay will be available approximately two hours following the presentation through Sept. 27. About NavientNavient (Nasdaq: NAVI) provides technology-enabled education finance and business processing solutions that simplify complex programs and help millions of people achieve success. Our customer-focused, data-driven services deliver...

Continue reading

Wayne Bank Ranks in Top 100 Performing Banks in U.S.

HONESDALE, Pa., Sept. 02, 2022 (GLOBE NEWSWIRE) — Wayne Bank, a subsidiary of Norwood Financial Corp (Nasdaq Global Market – NWFL), was recently ranked as one of the top 100 performing banks in the country by Bank Director magazine. Coming in at number seventy-one, Wayne Bank was evaluated on its profitability, capital adequacy, asset quality, and total shareholder return within the $1 Billion to $5 Billion asset size level. President and Chief Executive Officer of Wayne Bank, James O. Donnelly, commented, “It is an honor to be included in this prestigious list of financial institutions. As a 150-year old community bank, Wayne Bank is committed to creating shareholder value by investing in our employees, customers, and communities, and we will continue to operate with that philosophy as we grow.” Bank Director has analyzed the...

Continue reading

Immuneering Announces Submission of IND Application to the FDA for Phase 1/2a Trial of IMM-1-104 to Treat Advanced Solid Tumors with RAS Mutations

CAMBRIDGE, Mass., Sept. 02, 2022 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company using translational bioinformatics to advance a pipeline of product candidates designed to benefit large populations of patients with cancer and other diseases, today announced it submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA). The IND application supports a Phase 1/2a clinical trial of IMM-1-104, an oral once daily small molecule in development for the treatment of advanced RAS mutant solid tumors. In contrast to the narrow approach of targeting specific mutations such as KRAS-G12C, IMM-1-104 is a third generation MEK inhibitor designed for broad pan-RAS activity as well as activity in other MAPK-activated tumors. Based on preclinical data to date, IMM-1-104...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.